Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Leukemia

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1736012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

  1991cited by this paper
• Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

  1991cited by this paper
• The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.

  1991cited by this paper
• Mutations of the p53 gene in lymphoid leukemia.

  1991cited by this paper
• Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

  1990cited by this paper
• Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

  1990cited by this paper
• Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.

  1990cited by this paper
• Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia.

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia.

  1989cited by this paper
• Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.

  1989cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

  1988cited by this paper
• Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53.

  1987cited by this paper
• Localization of gene for human p53 tumour antigen to band 17p13

  1986cited by this paper

• Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor

  2022cites this paper
• New cellular models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor

  2021cites this paper
• Induction of Cell Death in the Human Acute Lymphoblastic Leukemia Cell Line Reh by Infection with Rotavirus Isolate Wt1-5

  2020cites this paper
• Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

  2019cites this paper
• Regulation of p53 and survivin by prodigiosin compound derived from Serratia marcescens contribute to caspase-3-dependent apoptosis in acute lymphoblastic leukemia cells

  2018cites this paper
• cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53

  2018cites this paper
• Fish-Oil-Derived DHA-mediated Enhancement of Apoptosis in Acute Lymphoblastic Leukemia Cells is Associated with Accumulation of p53, Downregulation of Survivin, and Caspase-3 Activation

  2017cites this paper
• Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells

  2015cites this paper
• Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death

  2015cites this paper
• Molecular characterisation of paediatric ALL and new therapeutic strategies

  2014cites this paper
• Genetic Variations in MDM2 and P53 Genes Confer Risk for Adult Acute Lymphoblastic Leukemia in a Chinese Population

  2013cites this paper
• Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.

  2013cites this paper
• lymphoblastic leukemia Mutations of the p53 and ras genes in childhood t(1;19)-acute

  2011cites this paper
• Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death

  2011cites this paper
• cancer cells: projection on the hematologic cell lineages Structure and function of p53 in normal cells and their aberrations in

  2011cites this paper
• Targeting survivin and p53 in pediatric acute lymphoblastic leukemia

  2011cites this paper
• Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians

  2010cites this paper
• Clinical manifestations of combined factor V and VIII deficiency: A series of 37 cases from a single center in India†

  2010cites this paper
• Analysis of the REL, BCL11A, and MYCN proto‐oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia†

  2010cites this paper
• Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease†

  2010cites this paper
• The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population†

  2010cites this paper
• A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B‐precursor acute lymphoblastic leukemia cell lines†

  2010cites this paper
• cAMP Signalling in Modification of DNA Damage Responses in Lymphoid Cells : Implications for Development and Treatment of BCP-ALL

  2010cites this paper
• Primary pulmonary non‐Hodgkin's lymphoma: A retrospective analysis of 29 cases in a Chinese population†

  2010cites this paper
• Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma†

  2010cites this paper
• Hematopoietic stem cell transplantation: ASBMT/CIBMTR 2010 tandem meeting highlights and discussion†

  2010cites this paper
• Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells

  2008cites this paper
• MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2

  2008cites this paper
• Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia.

  2007cites this paper
• Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines

  2006cites this paper
• Nachweis von Deletionen der Tumorsuppressorgene TP53 und p16 mittels Fluoreszenz-In-Situ-Hybridisierung bei erwachsenen Patienten mit Philadelphia-Chromosom- positiver akuter lymphatischer Leukämie (ALL)

  2006cites this paper
• EXPRESSION IN HAEMATOLOGICAL MALIGNANCIES : RESPONSE TO ALKYLATING AGENT IN THE COMET ASSAY

  2006cites this paper
• A role for mitotic recombination in leukemogenesis.

  2006cites this paper
• Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species.

  2005cites this paper
• The Expression of p 53 Protein in Non-Hodgkin ’ s Lymphomas Is Not Always Dependent on p 53 Gene Mutations

  2003cites this paper
• The immunohistochemical and serological determination of p53 protein in patients with malignant lymphomas.

  2002cites this paper
• Tumor suppressor genes in normal and malignant hematopoiesis

  2002cites this paper
• Mutations of the p 53 and ras Genes in Childhood t ( l ; 19 )-Acute Lymphoblastic Leukemia

  2002cites this paper
• Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.

  2001cites this paper
• Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation

  2001cites this paper
• Constitutive expression levels of CD95 and Bcl‐2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia

  2000cites this paper
• p53, bcl-2 and bax abnormalities in non-Hodgkin's lymphomas of the head and neck.

  2000cites this paper
• Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.

  1999cites this paper
• Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia.

  1999cites this paper
• A search for novel tumour suppressor genes for adult acute leukaemia by allelotyping at sub-telomeric chromosomal regions.

  1998cites this paper
• Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia.

  1998cites this paper
• Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: a longitudinal analysis.

  1998cites this paper
• Pooled analysis of p53 mutations in hematological malignancies

  1998cites this paper
• [p53 and hematologic malignancies].

  1997cites this paper
• THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIES

  1997cites this paper
• The non-random distribution of point mutations in leukaemia and myelodysplasia--a possible pointer to their aetiology.

  1997cites this paper
• Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.

  1997cites this paper
• Correlation between mutations in p53 gene and protein expression in human lymphomas

  1997cites this paper
• TP53 mutations in myelodysplastic syndrome.

  1996cites this paper
• Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma.

  1996cites this paper
• High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.

  1996cites this paper
• Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.

  1996cites this paper
• The relationship between the gene mutation of p53 and the protein expression of p53 and Ki‐67 in non‐Hodgkin's iymphomas

  1996cites this paper
• Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy.

  1996cites this paper
• A unique spectrum of p53 mutations in B‐cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies

  1995cites this paper
• MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression

  1995cites this paper
• Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.

  1995cites this paper
• Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.

  1995cites this paper
• Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.

  1995cites this paper
• PCR‐mismatch analysis of p53 gene mutation in Hodgkin's disease

  1995cites this paper
• Apoptosis in the embryo and tumorigenesis.

  1995cites this paper
• 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications.

  1995cites this paper
• P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance.

  1995cites this paper
• Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep.

  1995cites this paper
• Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.

  1995cites this paper
• p53 in Human Cancer

  1995cites this paper
• Tumour Suppressor Genes in Hodgkin’s Disease

  1995cites this paper
• Apoptosis in the Embryo and Tumorigenesis

  1995cites this paper
• The molecular basis of leukemia.

  1994cites this paper
• Progressive B‐cell chronic lymphocytic leukaemia frequently exhibits aberrant p53 expression

  1994cites this paper
• Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.

  1994cites this paper
• Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.

  1994cites this paper
• 寛解に再導入し得た成人ALL-L3 (Burkitt type)の1例

  1994cites this paper
• p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.

  1994cites this paper
• Low frequency of the p53 gene mutations in neuroblastoma

  1994cites this paper
• Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.

  1994cites this paper
• Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: Application to the detection of point mutations in acute leukemias

  1994cites this paper
• Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

  1994cites this paper
• p53 in hematologic malignancies.

  1994cites this paper
• p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.

  1993cites this paper
• [P53 genes and malignant hematologic diseases].

  1993cites this paper
• Molecular mechanisms of hematologic malignancies.

  1993cites this paper
• Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.

  1993cites this paper
• Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France.

  1993cites this paper
• The functions of the p53 gene and gene product

  1993cites this paper
• The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.

  1993cites this paper
• Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.

  1993cites this paper
• Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.

  1993cites this paper
• Rare occurrence of P53 gene mutations in multiple myeloma

  1992cites this paper
• Acute lymphoblastic leukemia: present and future.

  1992cites this paper